Swang Chai Chuan Limited (HKG:2321)
0.4600
+0.0450 (10.84%)
At close: Aug 1, 2025, 4:00 PM HKT
Elevation Oncology Revenue
In the year 2024, Swang Chai Chuan had annual revenue of 913.01M MYR, down -2.03%. Swang Chai Chuan had revenue of 441.25M in the half year ending December 31, 2024, with 1.21% growth.
Revenue
913.01M MYR
Revenue Growth
-2.03%
P/S Ratio
0.29
Revenue / Employee
1.00M MYR
Employees
909
Market Cap
460.07M USD
Revenue Chart
* This company reports financials in MYR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 913.01M | -18.91M | -2.03% |
Dec 31, 2023 | 931.92M | 96.01M | 11.49% |
Dec 31, 2022 | 835.91M | 167.17M | 25.00% |
Dec 31, 2021 | 668.74M | 104.11M | 18.44% |
Dec 31, 2020 | 564.63M | 67.20M | 13.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nongfu Spring | 45.65B |
MIXUE Group | 26.42B |
Smoore International Holdings | 12.56B |
Budweiser Brewing Company APAC | 46.97B |
WH Group | 201.50B |
Tsingtao Brewery Company | 34.77B |
China Resources Beer (Holdings) Company | 41.11B |
Want Want China Holdings | 25.21B |